OR WAIT 15 SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Eluemuno R. Blyden, PhD, is the founder and CEO of AfriVax, Inc.
Recombinant vector technologies can improve the yield and lower the cost of egg-based influenza vaccine production.